RD

Roberto De Ponti

3B FUTURE Health Ventures

Monte-Carlo, Monaco

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

Global

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Pharmaceutical Industry
Drug Delivery
R&D
Technology Transfer
Drug Development
Pharmaceutical Sciences
Pharmacology
Lifesciences
Clinical Development
GLP
Biotechnology
Business Development
Oncology
Pharmaceutics
Regulatory Affairs
Biopharmaceuticals
Pharmacovigilance
Validation
Product Development
Business Strategy

Investments

Fore Biotherapeutics

Series D

Total Funding: $130M

Geneos Therapeutics

Series A

Total Funding: $17M

Roca Therapeutics

Seed

Total Funding:

Domain Therapeutics

Series A

Total Funding: $47M

Work Experience

Geneos Therapeutics

2023

  • Board Observer

    2023

Epsilogen Ltd

2022

  • Board Observer

    2022

3B Future Health Fund I & II

2022

  • Managing Director and General Partner

    2022

iOnctura

2020

  • Board Observer

    2020

Claris Ventures SGR SpA

2020

  • Advisor

    2020

OncoResponse Inc.

2016

  • Board Member

    2016

Fore Biotherapeutics

2018 - 2023

  • Board Member

    2018 - 2023

GreenBone Ortho S.p.A.

2020 - 2022

  • Board Member

    2020 - 2022

Helsinn Group

2008 - 2021

  • Head, Corporate New Ventures and Strategic Investments

    2016 - 2021

  • Head, Corporate Business Development

    2008 - 2015

Aadi Bioscience, Inc

2017 - 2021

  • Board Observer

    2017 - 2021